Dongxiang Zeng

Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors.

A. Kalgutkar, T. Maurer, T. Zhu, 2011, Journal of medicinal chemistry.

The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus.

Michael D. Hamilton, J. Pfefferkorn, N. Barucci, 2012, Bioorganic & medicinal chemistry letters.

Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motif.

K. Gajiwala, M. Hickey, J. Pfefferkorn, 2013, Bioorganic & medicinal chemistry letters.

A Preliminary Approach to Nonenolizable β,β-Tricarbonyls: Assembly of a Hyperevolutin Prototype1

Dongxiang Zeng, D. J. Young, 2002 .

Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure.

A. Mathiowetz, D. Beebe, R. L. Dow, 2013, Journal of medicinal chemistry.